Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05689307 · ClinicalTrials.gov registry record · NA
Validation Study With a Non-CE Marked Medical Device (MD)
A NA study of Chronic Cough, sponsored by Siva Health.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05689307 is a NA study of Chronic Cough that has completed, run by Siva Health. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05689307, a NA study of Chronic Cough, has completed, sponsored by Siva Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This interventional study aims to validate the cough detection device by automatically and continuously measuring the cough frequency with SIVA-MVP among chronic cough patients and in a real-world environment.
Conditions Studied
Interventions
- DEVICE SIVA-MVP
Study Locations (1)
Washington
- Bellingham Asthma, Allergy & Immunology Clinic - Bellingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-03-02 |
| Est. Completion | 2024-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05689307
The ClinicalTrials.gov registry entry for NCT05689307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Siva Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Cough appearing as the primary indexed condition, and to 1 intervention - of which SIVA-MVP is the first listed.
NCT05689307 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05689307 about?
NCT05689307 is a clinical study titled "Validation Study With a Non-CE Marked Medical Device (MD)". This interventional study aims to validate the cough detection device by automatically and continuously measuring the cough frequency with SIVA-MVP among chronic cough patients and in a real-world environment.
What is the current status of trial NCT05689307?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-03-02. Estimated completion is 2024-11-22.
What conditions does trial NCT05689307 study?
This clinical trial studies the following conditions: Chronic Cough.
What interventions are being tested in trial NCT05689307?
The interventions under investigation include: SIVA-MVP (DEVICE).
Who is sponsoring clinical trial NCT05689307?
This trial is sponsored by Siva Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05689307 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Cough
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.